Head-To-Head Survey: Evofem Biosciences (NASDAQ:EVFM) and Ayala Pharmaceuticals (NASDAQ:ADXS)

Valuation and Earnings This table compares Ayala Pharmaceuticals and Evofem Biosciences"s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ayala Pharmaceuticals $3.24 million 11.05 -$48.07 million ($5.02) -0.12 Evofem Biosciences $11.39 million 0.10 $52.98 million ($0.03) -0.28 Evofem Biosciences has higher revenue and earnings